K. Ohene-frempong, Indications for red cell transfusion in sickle cell disease, Seminars in Hematology, vol.38, issue.1 1, pp.5-13, 2001.
DOI : 10.1016/S0037-1963(01)90055-1

E. Vichinsky, A. Earles, R. Johnson, M. Hoag, A. Williams et al., Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched Blood, New England Journal of Medicine, vol.322, issue.23, pp.1617-1638, 1990.
DOI : 10.1056/NEJM199006073222301

F. Noizat-pirenne, K. Lee, L. Pennec, P. Simon, P. Kazup et al., Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety, Blood, vol.100, issue.12, pp.4223-4254, 2002.
DOI : 10.1182/blood-2002-01-0229

F. Noizat-pirenne, Particularit??s immunoh??matologiques dans les populations africaines et antillaises. Implications transfusionnelles, Transfusion Clinique et Biologique, vol.10, issue.3, pp.185-91, 2003.
DOI : 10.1016/S1246-7820(03)00042-9

L. Scheunemann and K. Ataga, Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease, The American Journal of the Medical Sciences, vol.339, issue.3, pp.266-275, 2010.
DOI : 10.1097/MAJ.0b013e3181c70e14

J. Talano, C. Hillery, J. Gottschall, D. Baylerian, and J. Scott, Delayed haemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics, pp.111-661, 2003.

L. Petz, L. Calhoun, I. Shulman, C. Johnson, and R. Herron, The sickle cell hemolytic transfusion reaction syndrome, Transfusion, vol.37, issue.4, pp.382-92, 1997.
DOI : 10.1046/j.1537-2995.1997.37497265338.x

J. Cullis, N. Win, J. Dudley, and T. Kaye, Post-Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction, Vox Sanguinis, vol.67, issue.suppl, pp.355-362, 1995.
DOI : 10.1111/j.1423-0410.1995.tb00373.x

N. Win, H. Doughty, P. Telfer, B. Wild, and T. Pearson, Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, vol.73, issue.3, pp.323-331, 2001.
DOI : 10.1054/blre.1999.0121

J. Cox, E. Steane, G. Cunningham, and E. Frenkel, Risk of Alloimmunization and Delayed Hemolytic Transfusion Reactions in Patients With Sickle Cell Disease, Archives of Internal Medicine, vol.148, issue.11, pp.2485-2494, 1988.
DOI : 10.1001/archinte.1988.00380110115024

C. Tournamille, N. Meunier-costes, B. Costes, J. Martret, A. Barrault et al., Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization, Transfusion, vol.49, issue.1, pp.13-22, 2010.
DOI : 10.1111/j.1537-2995.2009.02382.x

P. Chadebech, A. Habibi, R. Nzouakou, D. Bachir, N. Meunier-costes et al., Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death, Transfusion, vol.2007, issue.9, pp.1785-92, 2009.
DOI : 10.1111/j.1537-2995.2009.02199.x

F. Noizat-pirenne, D. Bachir, P. Chadebech, M. Michel, A. Plonquet et al., Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease, Haematologica, vol.92, issue.12, pp.132-135, 2007.
DOI : 10.3324/haematol.12074

N. Elenga, V. Mialou, K. Kebaili, C. Galambrun, Y. Bertrand et al., Severe Neurologic Complication After Delayed Hemolytic Transfusion Reaction in 2 Children With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.30, issue.12, pp.928-958, 2008.
DOI : 10.1097/MPH.0b013e31818c9172

C. Bachmeyer, M. J. Parrot, A. Bachir, D. Stankovic, K. Girot et al., Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia, American Journal of Hematology, vol.85, issue.1, pp.91-93, 2010.
DOI : 10.1002/ajh.21578

J. Zimring and S. Spitalnik, To RBC or not to RBC: the role of suicidal death in hemolytic transfusion reactions, Transfusion, vol.129, issue.1, pp.1776-1784, 2009.
DOI : 10.1111/j.1537-2995.2009.02339.x

N. Neidlinger, S. Larkin, A. Bhagat, G. Victorino, and F. Kuypers, Hydrolysis of Phosphatidylserine-exposing Red Blood Cells by Secretory Phospholipase A2 Generates Lysophosphatidic Acid and Results in Vascular Dysfunction, Journal of Biological Chemistry, vol.281, issue.2, pp.775-81, 2006.
DOI : 10.1074/jbc.M505790200

E. Hod, S. Sokol, J. Zimring, and S. Spitalnik, Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis, Int J Clin Exp Pathol, vol.2, issue.1, pp.71-82, 2009.

O. Platt, Sickle cell anemia as an inflammatory disease, Journal of Clinical Investigation, vol.106, issue.3, pp.337-345, 2000.
DOI : 10.1172/JCI10726
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC314335

N. Choileain, N. Redmond, and H. , Cell Response to Surgery, Archives of Surgery, vol.141, issue.11, pp.1132-1172, 2006.
DOI : 10.1001/archsurg.141.11.1132

N. Win, S. Sinha, E. Lee, and W. Mills, Treatment With Intravenous Immunoglobulin and Steroids May Correct Severe Anemia in Hyperhemolytic Transfusion Reactions: Case Report and Literature Review, Transfusion Medicine Reviews, vol.24, issue.1, pp.64-71, 2010.
DOI : 10.1016/j.tmrv.2009.09.006

S. Couillard, M. Benkerrou, R. Girot, V. Brousse, A. Ferster et al., Steroid treatment in children with sickle-cell disease, Haematologica, vol.92, issue.3, pp.425-431, 2007.
DOI : 10.3324/haematol.10800

A. Crow and A. Lazarus, The Mechanisms of Action of Intravenous Immunoglobulin and Polyclonal Anti-D Immunoglobulin in the Amelioration of Immune Thrombocytopenic Purpura: What Do We Really Know?, Transfusion Medicine Reviews, vol.22, issue.2, pp.103-119, 2008.
DOI : 10.1016/j.tmrv.2007.12.001

A. Crow, S. Song, J. Semple, J. Freedman, and A. Lazarus, A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?, Blood, vol.109, issue.1, pp.155-163, 2007.
DOI : 10.1182/blood-2006-05-023796

S. Kurosawa and M. Kato, Anesthetics, immune cells, and immune responses, Journal of Anesthesia, vol.59, issue.1, pp.263-77, 2008.
DOI : 10.1007/s00540-008-0626-2